Title: N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Journal: Journal of medicinal chemistry 20110728
38922-74-6
88964-99-2
89185-45-5
80493-71-6
3999-29-9
65964-62-7
753394-01-3 | 2-[(2-Fluorobenzyl)thio]ethanamine | AA00J81Q | MFCD06655642
497853-95-9 | (4-Aminophenyl)(1-methyl-1h-imidazol-2-yl)methanol | AA00J9XX | MFCD06619337
861225-80-1 | 5-(1-Adamantylmethyl)-4-methyl-4h-1,2,4-triazole-3-thiol | AA00JC0R | MFCD04968886
1152522-12-7 | 1-Ethyl-2-(pyrrolidin-2-yl)-1h-1,3-benzodiazole | AA00JDPK | MFCD11103296
1006334-24-2 | 1-Cyclopentyl-1H-pyrazole-5-carboxylic acid | AA00JESW | MFCD06805235
1356543-56-0 | 4-bromo-5-(chloromethyl)-1-methyl-1H-pyrazole | AA00JG4K | MFCD24540439
6219-57-4 | 3-(4H-1,2,4-Triazol-3-yl)aniline | AA00JILP | MFCD07643240
36877-69-7 | Rhodamine B isothiocyanate, mixture of isomers | AA00JKFU | MFCD00041787
94514-21-3 | 5-Fluoroisoindoline-1,3-dione | AA00JNTR | MFCD00627750
640-19-7 | 2-fluoroacetamide | AA00JST5 | MFCD00008026